1. India Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Supriya Lifescience Limited

Supriya Lifescience Limited

SUPRIYA.BO
Supriya Lifescience LimitedIN flagBombay Stock Exchange
938.75
INR
+37.00
- -
75.55BMarket Cap

Total Valuation

Supriya Lifescience Limited carries a market capitalization of 75.55B, placing it among publicly traded companies globally. Its enterprise value stands at 44.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap75.55B
Enterprise Value44.75B

Share Statistics

Supriya Lifescience Limited currently has 80.48M shares outstanding.

Shares Outstanding80.48M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Supriya Lifescience Limited trades at a trailing price-to-earnings ratio of 21.75. The price-to-sales ratio is 5.49, and the price-to-book ratio stands at 282.58.

PE Ratio21.75
PS Ratio5.49
PB Ratio282.58
P/TBV Ratio3.80
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Supriya Lifescience Limited trades at an EV/EBITDA multiple of 16.85 and an EV/FCF ratio of 3,112.98. The EV/Sales ratio of 5.41 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.85 provides insight into valuation relative to core operating earnings.

EV / Sales5.41
EV / EBITDA16.85
EV / EBIT16.85
EV / FCF3,112.98

Financial Position

Supriya Lifescience Limited maintains a current ratio of 4.40, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.45, indicating conservative leverage, while an interest coverage ratio of 140.62 demonstrates strong ability to service its debt obligations.

Current Ratio4.40
Quick Ratio0.65
Debt / Equity0.45
Debt / EBITDA0.02
Interest Coverage140.62

Financial Efficiency

Supriya Lifescience Limited posts a return on equity of 51.37 and a return on invested capital of 18.38.

Return on Equity (ROE)51.37
Return on Assets (ROA)16.94
Return on Invested Capital (ROIC)18.38
Return on Capital Employed (ROCE)51.05
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.83

Taxes

Over the trailing twelve months, Supriya Lifescience Limited has paid 656.58M in income taxes, reflecting an effective tax rate of 23.89.

Income Tax656.58M
Effective Tax Rate23.89

Stock Price Statistics

Supriya Lifescience Limited's stock has gained approximately 34.07841% over the past 52 weeks. The 50-day moving average sits at 685.46, while the 200-day moving average is 701.17.

Beta (5Y)N/A
52-Week Price Change34.07841%
50-Day Moving Average685.46
200-Day Moving Average701.17
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Supriya Lifescience Limited generated 8.28B in revenue and converted that into 2.09B in net income, yielding earnings per share of 25.98. EBITDA reached 2.66B, while operating income came in at 2.66B.

Revenue8.28B
Gross Profit5.74B
Operating Income2.66B
Pretax Income2.75B
Net Income2.09B
EBITDA2.66B
EBIT2.66B
Earnings Per Share (EPS)25.98

Balance Sheet

Supriya Lifescience Limited holds 788.67M in cash and equivalents against 54.35M in total debt, resulting in a net debt position of -375.46M. Total book value stands at 160.97M, with working capital of 4.11B providing operational flexibility.

Cash & Cash Equivalents788.67M
Total Debt54.35M
Net Debt-375.46M
Equity (Book Value)160.97M
Book Value Per Share2.00
Working Capital4.11B

Margins

Supriya Lifescience Limited operates with a gross margin of 69.32, reflecting its pricing power and cost economics. The operating margin of 32.09 and net profit margin of 25.26 provide insight into operational efficiency.

Gross Margin69.32
Operating Margin32.09
Pretax Margin33.19
Profit Margin25.26
EBITDA Margin32.09

Scores

Supriya Lifescience Limited posts an Altman Z-Score of 18.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score18.75